Kynos Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Edinburgh
Industry:BiotechHealth servicesManufacturing
Business model:B2B
Kynos Therapeutics is a health company from UK that develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 8.56M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Kynos Therapeutics
| Name | Criteria | |
|---|---|---|
![]() |
Biograil
63%
|
|
![]() |
Cell-Easy
63%
|
|
![]() |
Bactolife
63%
|
|
![]() |
Integra Tx
63%
|
|
![]() |
Sixfold Bioscience
63%
|
|
![]() |
Synerkine Pharma
63%
|
|
![]() |
Oncorena
63%
|
|
![]() |
Cebiotex
60%
|
|
![]() |
Intrance Medical Systems
60%
|
|
![]() |
CatalYm
58%
|
|







Belgium
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal